Program
Microbial Collagenase
Also written as “EN3835”, “Santyl” and “AA4500”.
Its studies are mostly in Cellulite · Penile Induration · Dupuytren Contracture · Diabetic Foot · Bursitis, led by 5 companies.
Drug pageMicrobial Collagenase: every studyMany companies study it; this page follows only the 42 they lead. All 71 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Keenova Therapeutics | 382 open or running | phase 4since Dec 17, 2011 | Sep 11, 2007 | Dec 2027phase 3 · NCT07759362 |
| Advance Biofacturesits history only | 10 open or running | phase 1since Aug 22, 2016 | Aug 22, 2016 | none ahead |
| Asahi Kasei Therapeuticsits history only | 10 open or running | phase 3since Apr 27, 2012 | Apr 27, 2012 | none ahead |
| Luxurgeryits history only | 10 open or running | phase 4since Mar 24, 2022 | Mar 24, 2022 | none ahead |
| Manhattan Medical Research Practice, PLLCits history only | 10 open or running | phase 4since Nov 30, 2018 | Nov 30, 2018 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Keenova Therapeutics only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 24 studies since Sep 11, 2007.
- Jul 5, 2018Phase 2 study in CelluliteNCT03632993 · 64 enrolled · United States
- Sep 15, 2018Phase 1 study in CelluliteNCT03675685 · 12 enrolled · United States
- Nov 18, 2019Phase 3 study in CelluliteNCT04170296 · 153 enrolled · United States, Puerto Rico
- Dec 11, 2019Phase 2 study in CelluliteNCT04209530 · 7 enrolled · United States
- Jan 2, 2020Phase 2 study in Characteristics of Subcutaneous TissueNCT04236635 · 10 enrolled · United States
- Jul 29, 2020Phase 2 study in BursitisNCT04496167 · 198 enrolled · United States
- Oct 2, 2020Phase 2 study in CelluliteNCT04580303 · 35 enrolled · United States
- Nov 29, 2021Phase 2 study in Fibromatosis, PlantarNCT05152173 · 176 enrolled · United States
- Feb 15, 2022Phase 3 study in Fibromatosis, PlantarNCT05254457 · 145 enrolled · United States
- Jun 9, 2022Phase 2 study in CelluliteNCT05419505 · 91 enrolled · United States
- Nov 21, 2023Phase 3 study in Fibromatosis, PlantarNCT06151197 · 436 enrolled · United States, Puerto Rico
- Dec 5, 2023Phase 2 study in Fasciitis, PlantarNCT06169319 · 231 enrolled · United States
- Aug 7, 2026Phase 3 study in Flexible HammertoeNCT07759362 · 554 planned · United States
- Sep 23, 2026Phase 3 study in Flexible HammertoeNCT07846280 · 470 planned · United States
Ahead
- Dec 2027Primary completion: phase 3 study in Flexible HammertoeNCT07759362
- Dec 2028Primary completion: phase 3 study in Flexible HammertoeNCT07846280
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 38 Keenova Therapeutics leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07846280Flexible Hammertoe · United States | 3 | Recruiting | Dec 2028 | 470 |
| NCT07759362Flexible Hammertoe · United States | 3 | Recruiting | Dec 2027 | 554 |
| NCT06169319Fasciitis, Plantar · United States | 2 | Completed | Sep 30, 2024 | 231 |
| NCT06151197Fibromatosis, Plantar · United States, Puerto Rico | 3 | Completed | Jun 9, 2026 | 436 |
| NCT05419505Cellulite · United States | 2 | Completed | Jan 3, 2023 | 91 |
| NCT05254457Fibromatosis, Plantar · United States | 3 | Completed | Mar 21, 2024 | 145 |
| NCT05152173Fibromatosis, Plantar · United States | 2 | Completed | Jan 10, 2023 | 176 |
| NCT04580303Cellulite · United States | 2 | Completed | Aug 30, 2021 | 35 |
| NCT04496167Bursitis · United States | 2 | Completed | Apr 14, 2022 | 198 |
| NCT04236635Characteristics of Subcutaneous Tissue · United States | 2 | Completed | Sep 23, 2020 | 10 |
| NCT04209530Cellulite · United States | 2 | Terminated | Jul 23, 2020 | 7 |
| NCT04170296Cellulite · United States, Puerto Rico | 3 | Completed | Oct 6, 2020 | 153 |
| NCT03675685Cellulite · United States | 1 | Completed | Nov 1, 2018 | 12 |
| NCT03632993Cellulite · United States | 2 | Completed | Jan 24, 2019 | 64 |
| NCT03526549Cellulite · United States | 3 | Completed | Oct 8, 2021 | 483 |
| NCT03446781Cellulite · United States | 3 | Completed | Sep 26, 2018 | 422 |
| NCT03428750Cellulite · United States | 3 | Completed | Sep 26, 2018 | 423 |
| NCT03329989Cellulite · United States | 2 | Completed | Sep 5, 2018 | 158 |
| NCT02942160Cellulite · United States | 2 | Completed | Jun 14, 2018 | 259 |
| NCT02724644Cellulite · United States | 2 | Completed | Sep 2016 | 375 |
| NCT02193828Dupuytren Contracture · United States, Australia | 2 | Completed | Dec 2014 | 76 |
| NCT02006719Bursitis · United States, Australia | 2 | Completed | Dec 2014 | 322 |
| NCT01987986Cellulite · United States | 2 | Completed | Aug 2014 | 150 |
| NCT01685437Penile Induration | 3 | Completed | Dec 2013 | 189 |
| NCT01518907Cellulite · United States | 1 | Completed | Dec 2012 | 99 |
| NCT01498640Dupuytren Contracture · United States, Australia, Sweden and more | 4 | Completed | Oct 2013 | 52 |
| NCT01483963Bursitis · United States | 2 | Completed | Feb 2013 | 50 |
| NCT01430169Penile Induration · United States | 2 | Completed | Nov 2011 | 20 |
| NCT01407068Dupuytren Contracture · United States, Australia | 3 | Completed | Feb 2012 | 60 |
| NCT01243411Penile Induration · United States, Denmark, France and more | 3 | Completed | Aug 2012 | 348 |
| NCT01221623Penile Induration · United States, Australia | 3 | Completed | Mar 2012 | 418 |
| NCT01221597Penile Induration · United States, Australia | 3 | Completed | Apr 2012 | 418 |
| NCT00755222Penile Induration · United States | 2 | Completed | Dec 2009 | 147 |
| NCT00533273Advanced Dupuytren's Disease · Australia | 3 | Completed | Sep 2008 | 66 |
| NCT00528931Dupuytren Contracture · United States | 1 | Completed | Dec 2007 | 16 |
| NCT00528840Advanced Dupuytren's Disease · United States | 3 | Completed | Oct 2008 | 201 |
| NCT00528606Dupuytren Contracture · United States | 3 | Completed | Apr 2008 | 308 |
| NCT00528424Advanced Dupuytren's Disease · United States | 3 | Completed | Nov 2008 | 286 |
How it is read
Names in the registry
- “EN3835”, 9 entries
- “Santyl”, 7 entries
- “AA4500”, 7 entries
- “collagenase clostridium histolyticum”, 5 entries
- “Collagenase Clostridium Histolyticum”, 5 entries
Conditions, from the studies’ own filings
- Cellulite, 15 studies
- Penile Induration, 7 studies
- Dupuytren Contracture, 6 studies
- Diabetic Foot, 5 studies
- Bursitis, 3 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.